These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11535815)

  • 1. Replication of enhancer-deficient amphotropic murine leukemia virus in human cells.
    Reuss FU; Berdel B; Ploss M; Heber R
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10898-903. PubMed ID: 11535815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional inactivation of amphotropic murine leukemia virus replication in human cells.
    Ploss M; Berdel B; Heber R; Reuss FU
    J Med Virol; 2003 Feb; 69(2):267-72. PubMed ID: 12683417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of enhancer-deficient amphotropic murine leukemia virus in human fibrosarcoma but not in primary human fibroblasts.
    Reuss FU; Berdel B; Heber R; Bantel-Schaal U
    J Med Virol; 2002 Oct; 68(2):278-84. PubMed ID: 12210420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotropic murine leukemia virus replication in human mammary epithelial cells and the formation of cytomegalovirus-promoter recombinants.
    Reuss FU; Heber R; Ploss A; Berdel B
    Virology; 2001 Dec; 291(1):91-100. PubMed ID: 11878879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer-deficient amphotropic murine leukemia virus and recombinants with heterologous transcription elements can be efficiently amplified and detected in Mus dunni fibroblasts.
    Reuss FU; Berdel B; Heber R; Ploss M
    Gene Ther; 2002 Sep; 9(17):1183-8. PubMed ID: 12170382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
    Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
    J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
    Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
    Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers.
    Modin C; Lund AH; Schmitz A; Duch M; Pedersen FS
    Virology; 2000 Dec; 278(2):368-79. PubMed ID: 11118360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementarity between RNA dimerization elements favors formation of functional heterozygous murine leukemia viruses.
    Rasmussen S; Pedersen FS
    Virology; 2004 Nov; 329(2):440-53. PubMed ID: 15518822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient replication of full-length murine leukemia viruses modified at the dimer initiation site regions.
    Aagaard L; Rasmussen SV; Mikkelsen JG; Pedersen FS
    Virology; 2004 Jan; 318(1):360-70. PubMed ID: 14972561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence.
    Torrent C; Wang P; Darlix JL
    Bone Marrow Transplant; 1992; 9 Suppl 1():143-7. PubMed ID: 1324044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine leukemia virus (MLV) replication monitored with fluorescent proteins.
    Sliva K; Erlwein O; Bittner A; Schnierle BS
    Virol J; 2004 Dec; 1():14. PubMed ID: 15610559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of replication competent retroviruses derived from mouse cells in immunosuppressed primates: implications for use of neoplastic cells as vaccine substrates.
    Purcell DF
    Dev Biol (Basel); 2001; 106():187-98; discussion 199, 253-63. PubMed ID: 11761231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
    Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
    J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.
    Yoshimura FK; Wang T
    Virology; 2001 Apr; 283(1):121-31. PubMed ID: 11312668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles of enhancer nuclear factor 1 (NF1) sites in plasmacytoma and osteopetrosis induction by Akv1-99 murine leukemia virus.
    Sørensen KD; Sørensen AB; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
    Virology; 2005 Apr; 334(2):234-44. PubMed ID: 15780873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of replication-competent oncolytic retroviral vectors expressing R peptide-truncated 10A1 envelope glycoprotein.
    Lee ES; Jin SY; Kang BK; Jung YT
    J Virol Methods; 2019 Jun; 268():32-36. PubMed ID: 30898575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
    Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
    J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors.
    Metzl C; Mischek D; Salmons B; Günzburg WH; Renner M; Portsmouth D
    J Virol; 2006 Jul; 80(14):7070-8. PubMed ID: 16809312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
    Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
    Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.